AXSOME THERAPEUTICS INC. - COMMON STOCK

121,91

14-марта-25 16:45:00

15 мин. задержка

Акции

+0,26

+0,21%

Сегодняшний диапазон

120,52 - 123,47

ISIN

N/A

Источник

NASDAQ

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

13 ноя 2024 09:49:44 Источник NetDania Notify
NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

12 ноя 2024 10:02:19 Источник NetDania Notify
Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

12 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024

08 ноя 2024 07:00:28 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024

29 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12

15 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024

24 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine

04 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics to Participate in Investor Conferences in September

27 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.

21 авг 2024 07:00:39 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

05 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5

11 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories

05 июн 2024 07:35:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month

04 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month

03 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics to Participate in Upcoming Investor Conferences

30 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

29 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting

28 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics to Present at Upcoming Investor Conferences

08 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

06 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.